Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0590
+0.0010 (1.72%)
At close: Mar 27, 2026
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 18.13 million as of March 27, 2026. Its market cap has decreased by -28.70% in one year.
Market Cap
18.13M
Enterprise Value
22.28M
Revenue
3.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 18.13M, an increase of 30.35%. That is a compound annual growth rate of 2.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 18.13M | -33.30% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EZZ Life Science Holdings | 40.24M |
| Avecho Biotechnology | 33.06M |
| Algorae Pharmaceuticals | 27.47M |
| NeuroScientific Biopharmaceuticals | 27.27M |
| Argenica Therapeutics | 21.20M |
| Patrys | 15.53M |
| Neurotech International | 14.26M |
| Bio-Gene Technology | 10.68M |